https://www.selleckchem.com/products/amg-487.html
Subgroup analysis demonstrated that neither age nor N stage were informative in TI selection; in contrast, in patients with large tumors, a short TI was associated with better DFS than a long TI. In patients with small tumors, there was no significant association between TI and tumor prognosis. In the multivariable analysis, TI was independent predictor of DFS and local recurrence-free survival in patients with large tumors. Large tumor size is an indicator for the timely administration of adjuvant radiotherapy in luminal breast cancer
Like
Comment
Share
